Anticoagulation régionale au citrate pour l’épuration extrarénale continue [Regional citrate anticoagulation for continuous renal replacement therapy]

Détails

ID Serval
serval:BIB_4B7E90352BE4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Anticoagulation régionale au citrate pour l’épuration extrarénale continue [Regional citrate anticoagulation for continuous renal replacement therapy]
Périodique
Revue medicale suisse
Auteur(s)
Bezençon E., Ferlay C., Alouazem K., Plouhinec V., Schneider A.G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
21/10/2020
Peer-reviewed
Oui
Volume
16
Numéro
711
Pages
2002-2006
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
Regional citrate anticoagulation (RCA) is currently the recommended anticoagulation modality for continuous renal replacement therapy. Indeed, compared with systemic heparinization, RCA is associated with a lower risk of bleeding, a longer circuit lifespan and a decrease nursing workload. However, RCA requires a strict protocol to be followed, as it might be associated with potentially severe complications, such as citrate accumulation. Citrate accumulation is rare and usually associated with specific situations : severe circulatory shock, liver failure and mitochondrial dysfunction. According to centers' expertise, these situations might represent contra-indications to RCA. This review presents RCA, its mode of action, associated risks and proposes an algorithm for patients' selection.
Pubmed
Création de la notice
26/10/2020 14:30
Dernière modification de la notice
20/01/2021 7:26
Données d'usage